SN

Surendra Nath Tripathi

Active Director Director DIN 07875659
DIN 07875659 First appointment Sep 2017 Primary industry Non-Profit Organizations
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2017
Shareholding value •••• Premium profile

About Surendra Nath Tripathi

Data last updated:

Surendra Nath Tripathi is a Director at Felding Roth Pharmaceuticals Private Limited (since 2017). The company operates in Non-Profit Organizations. Felding Roth Pharmaceuticals Private Limited reported revenue of ₹6 Lakh (FY 2025).

DIN 07875659
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 25 Sep 2017
Oldest Company Age 9 yrs
Largest company Felding Roth Pharmaceuticals Private Limited · ₹6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Sep 20172017₹6 Lakh (FY 2025)Active

Board colleagues of Surendra Nath Tripathi

Directorship timeline

Open interactive timeline →
Felding Roth Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Surendra Nath Tripathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surendra Nath Tripathi

Surendra Nath Tripathi currently holds 1 directorship: Felding Roth Pharmaceuticals Private Limited (Director, since 25 Sep 2017, revenue ₹6 Lakh (FY 2025)).

Surendra Nath Tripathi was first appointed on 25 Sep 2017 as Director at Felding Roth Pharmaceuticals Private Limited.

The current boards of Surendra Nath Tripathi's companies include Meenakshi Tripathi (Felding Roth Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available